Odronextamab not checked

Regeneron · REGN1979 · R1979

FollowEvery change as it happens, and a Monday email
Stage
in the EU and EU
Next date
Phase 3 trial completes
Trials
10 active
11 in total · 9 in the EU
Targets
 

What this is

How it works
An antibody: a lab-made immune protein built to latch onto one target in the body.-mab: monoclonal antibodies WHO name stem
How it’s given
“Odronextamab will be administered by intravenous (IV) infusion”In the company’s words, NCT06091865 on ClinicalTrials.gov
Tested for
Follicular Lymphoma (FL) (2 trials), Diffuse Large B-cell Lymphoma (DLBCL) (2 trials), B-Cell Non-Hodgkin Lymphoma (B-NHL) (2 trials), Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL), B-cell Non-Hodgkins Lymphoma (B-NHL), Lupus Nephritis (LN)
Main trialPhase 3
“This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL). This study will be made up of two parts: Part 1 (non-randomized) and Part 2 (randomized - controlled). The aim of Part 1 of the study is to see how safe and tolerable the study drug is when given alone. The aim of Part 2 of the study is to see how the study drug works compared to rituximab (called the "comparator drug") and chemotherapy (the current standard of care for…”In the company’s words, NCT06091254 on ClinicalTrials.gov
Other names
REGN1979 · Ordspono · R1979

Other drugs for Follicular Lymphoma (FL)

All 76 drugs for Follicular Lymphoma (FL)

Coming up8

Changes1

Last 90 days

Trials11

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 29 Feb 2028 A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Phase 3Recruiting 30 Mar 2028 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Phase 3Active, not recruiting 29 May 2028 A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
Phase 3Active, not recruiting 29 Jul 2029 A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
Phase 3Recruiting 30 Apr 2031 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Phase 2Active, not recruiting 17 Jun 2026 A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
Phase 1/2Not yet recruiting 1 Nov 2029 REGN9220 in Combination With Odronextamab in Adult Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas (BCNHLs)
Phase 1Recruiting 16 Feb 2029 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Phase 1Recruiting 10 Sep 2029 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1Completed 29 Apr 2026 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies
Phase 2/3Authorised not given Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Odronextamab

Following is part of Solo: you see every change to Odronextamab the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in